National Center for Tumor Diseases (NCT) Heidelberg
Stella Arelaki is a Postdoctoral Research Fellow at the National Center for Tumor Diseases (NCT) Heidelberg, a position held since July 2019. Prior to this role, Stella Arelaki served as a Medical Doctor at the Department of Pathology, School of Medicine, AUTH from November 2017 to June 2019, and at the Department of Pathology, DUTH from July 2013 to October 2017.
National Center for Tumor Diseases (NCT) Heidelberg
The National Center for Tumor Diseases (NCT) Heidelberg is a joint institution of the German Cancer Research Center (DKFZ), Heidelberg University Hospital and German Cancer Aid. The NCT's goal is to link promising approaches from cancer research with patient care from diagnosis to treatment, aftercare and prevention. The interdisciplinary tumor outpatient clinic is the central element of the NCT. Here the patients benefit from an individual treatment plan prepared in a timely manner in interdisciplinary expert rounds, the so-called tumor boards. Participation in clinical studies provides access to innovative therapies. The NCT thereby acts as a pioneering platform that translates novel research results from the laboratory into clinical practice. The NCT cooperates with self-help groups and supports them in their work. Since 2015, a second site for the NCT beside Heidelberg has been under development in Dresden.